| Title |
Chemotherapy versus best supportive care for extensive small cell lung cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2013
|
| DOI | 10.1002/14651858.cd001990.pub3 |
| Pubmed ID | |
| Authors |
Marta Pelayo Alvarez, Virginie Westeel, Marcela Cortés‐Jofré, Xavier Bonfill Cosp |
| Abstract |
Combination chemotherapy has been the mainstay of treatment for extensive stage small celI lung cancer (SCLC) over the last 30 years, even though it only gives a short prolongation in median survival time. The main goal for these patients should be palliation with the aim of improving their quality of life. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 40% |
| Canada | 1 | 10% |
| Unknown | 5 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 70% |
| Practitioners (doctors, other healthcare professionals) | 3 | 30% |
Mendeley readers
The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | <1% |
| Unknown | 176 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 15% |
| Student > Bachelor | 20 | 11% |
| Researcher | 19 | 11% |
| Student > Ph. D. Student | 18 | 10% |
| Student > Doctoral Student | 11 | 6% |
| Other | 24 | 14% |
| Unknown | 58 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 71 | 40% |
| Nursing and Health Professions | 12 | 7% |
| Psychology | 6 | 3% |
| Agricultural and Biological Sciences | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 16 | 9% |
| Unknown | 62 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#4,555,917
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,737
of 11,499 outputs
Outputs of similar age
#49,656
of 320,379 outputs
Outputs of similar age from Cochrane database of systematic reviews
#137
of 218 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,379 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 218 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.